The Genetic Role of Ozempic and the Weight loss Benefits

 

    With the recent development of GLP-1 for weight loss growing across the nation the carrying success rates has raised question on genetic influences of results. Whole a large quantity of patients sees life-changing results there is still about 15% of patients who see no change. An eye-opening by Cleaveland Clinic in September of 2025, dove into the genetic factors that could explain why 15% of patients do not see results and genetic factors related to those statistics.

    Specifically, the study focused on the GLP1R gene, which is a gene that provides the receptor building blueprint in our bodies that correlate to the GLP-1 hormone. The study demonstrated that variation in the GLP1R gene directly impact how the receptors interact with the hormone/mediation. While genetic variation of the GLP1R gene is irreversible these finding still hold value as the knowledge can be used in precision medicine.

    Weight loss medication is expensive, especially if it is for cometic weight loss, which is rarely covered by insurance. These findings could allow patients to participate in a genetic test that could indicate the results they may see on the medication. With the implementation of GLP-1’s to a large percentage of individuals, knowing there are gentic influences on results is very crucial financially, mentally, and physically for patients and doctors.

Tags: #GLP-1 #GLP1Rgene #Genetics #Weightloss #Genevariations

Sources: 

https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16612?af=R 

https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16612?af=R